Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia

被引：0
|
作者：
Sakaguchi, Hirotoshi [1 ]
Maemura, Ryo [1 ]
Yamamori, Ayako [1 ]
Wakamatsu, Manabu [1 ]
Yoshida, Nao [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O29-3-1
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [31] The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia
    Benjamin, Jonathan E.
    Stein, Anthony S.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 142 - 156
  • [32] Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults: Progress and Challenges
    Guru Murthy, Guru Subramanian
    Atallah, Ehab
    JCO ONCOLOGY PRACTICE, 2022, 18 (07) : 489 - +
  • [33] A novel immunotherapy for relapsed/refractory acute lymphoblastic leukemia (ALL)
    Saini, Uksha
    Hixon, Julie
    Rodrigues, Gisele
    Foley, Christopher
    Chibas, Leniher Castan
    Hamilton, Ross
    Li, Wenqing
    Schafer, Eric S.
    Rheingold, Susan
    Heffernan, Michael
    Breitfeld, Philip
    Durum, Scott
    Varadhachary, Atul
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Immunotherapy of refractory and relapsed acute lymphoblastic leukemia in childhood and adolescence
    Kramm, CM
    Kameda, G
    Bader, P
    Dilloo, D
    MONATSSCHRIFT KINDERHEILKUNDE, 2003, 151 (02) : 154 - 165
  • [35] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adult Patients
    Oriol, Albert
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 89 - 90
  • [36] Tailored therapy for relapsed or refractory childhood acute lymphoblastic leukemia
    Agthe, AG
    Dorffel, W
    Neuendank, A
    Hartmann, R
    Bruhmuller, S
    Klumper, E
    Pieters, R
    Veerman, AJP
    Henze, G
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 51 - 57
  • [37] Importance of blinatumomab in relapsed or refractory acute lymphoblastic leukemia B
    Machet, Antoine
    Gallego-Hernanz, Pilar
    Torregrosa-Diaz, Jose
    Leleu, Xavier
    HEMATOLOGIE, 2016, 22 (01): : 17 - 18
  • [38] Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    Alexander, Thomas
    Lacayo, Norman J.
    Pullarkat, Vinod A.
    Jabbour, Elias J.
    Khaw, Seong Lin
    Mullighan, Charles G.
    Bajel, Ashish
    Leonard, Jessica
    Norris, Robin
    Rubnitz, Jeffrey
    Vear, Susan I.
    Schmidt, Michelle
    Tong, Bo
    Zhou, Ying
    Ross, Jeremy A.
    Rosenwinkel, Lindsey
    Jacobson, Amanda
    Kim, Su Young
    Stock, Wendy
    BLOOD, 2018, 132
  • [39] Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis
    Baruchel, Andre
    Abrahamsson, Jonas
    Bertrand, Yves
    Gonzalez, Oscar
    Nysom, Karsten
    Quinones, Willy
    Rizzari, Carmelo
    Buechner, Jochen
    Cesaro, Simone
    Duarte, Joaquin
    Fagioli, Franca
    Kang, Hyoung Jin
    Kattamis, Antonis
    Leverger, Guy
    Ludwig, Kathleen
    Makiya, Monica L.
    Micalizzi, Concetta
    Nelken, Brigitte
    Tondel, Camilla
    Yoo, Keon Hee
    Ivanina, Inna
    Brillac, Claire
    Wang, Lynn
    Oprea, Corina
    Abbadessa, Giovanni
    Zwaan, C. Michel
    BLOOD, 2021, 138
  • [40] Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia
    Guan, Wei
    Jing, Yu
    Dou, Liping
    Wang, Maoquan
    Xiao, Yang
    Yu, Li
    LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 855 - 861
12345